This site is intended for healthcare professionals only
LoginRegister
Two doses of recombinant zoster vaccine provides strong protection over 4 years even in immunocompromised patientsTwo doses of recombinant zoster vaccine provides strong protection over 4 years even in...
Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claimsIndian Immunologicals starts work on veterinary vaccine facility in Hyderabad
High-Dose Recombinant Vaccine may Enhance Protection Against Influenza among Adults Aged 50-64High-Dose Recombinant Vaccine may Enhance Protection Against Influenza among Adults Aged 50-64
Biological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80 years oldBiological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80...
R21 Vaccine Not for India Yet, Government Informs ParliamentWHO Adds R21/Matrix-M Malaria Vaccine to Prequalified List
R21 Vaccine Not for India Yet, Government Informs ParliamentWHO adds SII-Oxford University Malaria vaccine to its list of prequalified vaccines
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adultsUSFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine...
Maternal influenza vaccination during pregnancy may protect infant in first few months of life: JAMAMaternal influenza vaccination during pregnancy may protect infant in first few months of life: JAMA
National Vaccination Day: SignificanceACOG Recommendations Highlight Importance of Influenza Vaccination for Pregnant women
State-Wide Immunization Drive in Haryana Targets High-Risk AreasMelanoma vaccine could be available by 2025: Moderna CEO
State-Wide Immunization Drive in Haryana Targets High-Risk AreasJapan accepts GSK Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at...
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USAAstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion
X